This is also likely attributed to distinct requirements of Nrf1 and Nrf2 for regulating the constructive and inducible expression of those key genes involved in redox metabolic reprogramming in cancer development and malignance (Figure 14) 115, 264. This evidence concerns the gene NFE2L2 and cancer.